Trulieve Cannabis (TCNNF) Income towards Parent Company (2020 - 2026)
Trulieve Cannabis (TCNNF) recorded quarterly Income towards Parent Company of -$1.1 million in Q1 2026, down 179.62% quarter-over-quarter from $1.4 million in Q4 2025, and up 33.54% on a YoY basis from -$807255.8 in Q1 2025.
Trulieve Cannabis (TCNNF) Income towards Parent Company (2020 - 2026) Analysis & Trends
Trulieve Cannabis' Income towards Parent Company history runs 7 years deep, the most recent figure standing at -$1.1 million for Q1 2026.
- In Q1 2026, Income towards Parent Company rose 33.54% year-over-year to -$1.1 million; the TTM figure through Mar 2026 stood at -$5.1 million (up 15.05% YoY), while the FY2025 annual figure was -$5.6 million, up 1.58% from the prior year.
- Income towards Parent Company was -$1.1 million for Q1 2026 at Trulieve Cannabis, down from $1.4 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $1.8 million in Q4 2023 to a low of -$64.8 million in Q2 2023.
- Historically, Income towards Parent Company has averaged -$10.2 million across 5 years, with a median of -$1.6 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Income towards Parent Company sank 1205.98% in 2023, then jumped 224.33% in 2025.
- A 5-year view of Income towards Parent Company shows it stood at -$14.3 million in 2022, then soared by 112.71% to $1.8 million in 2023, then plunged by 160.07% to -$1.1 million in 2024, then surged by 224.33% to $1.4 million in 2025, then plunged by 179.62% to -$1.1 million in 2026.
- The last three Income towards Parent Company figures came in at -$1.1 million (Q1 2026), $1.4 million (Q4 2025), and -$5.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Trulieve Cannabis | - | - | 170.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.08 Mn |
| Dec 31, 2025 | 1.35 Mn |
| Sep 30, 2025 | -5.05 Mn |
| Jun 30, 2025 | -295,000.00 |
| Mar 31, 2025 | -1.62 Mn |
| Dec 31, 2024 | -1.09 Mn |
| Sep 30, 2024 | -1.64 Mn |
| Jun 30, 2024 | -1.62 Mn |
| Mar 31, 2024 | -1.36 Mn |
| Dec 31, 2023 | 1.81 Mn |
| Sep 30, 2023 | -2.93 Mn |
| Jun 30, 2023 | -64.80 Mn |
| Mar 31, 2023 | -30.81 Mn |
| Dec 31, 2022 | -14.26 Mn |
| Sep 30, 2022 | -42.45 Mn |
| Jun 30, 2022 | -5.23 Mn |
| Mar 31, 2022 | -2.36 Mn |
| Dec 31, 2021 | -59.05 Mn |
| Sep 30, 2021 | 18.62 Mn |
| Jun 30, 2021 | 40.88 Mn |